Impact News +++ Amazon-Aktie: Neues Feuer im Satelliten-Krieg (Sharedeals) +++ GLOBALSTAR Aktie +3,22%

ALGERNON HEALTH Aktie

>ALGERNON HEALTH Performance

1 Woche: -1,1%

1 Monat: +47,5%

3 Monate: 0%

6 Monate: 0%

1 Jahr: 0%

laufendes Jahr: 0%

>ALGERNON HEALTH Aktie

Name:

ALGERNON HEALTH INC. A

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA01559C1068 / A41QK7

Symbol/ Ticker:

AGW2 (Frankfurt)

Kürzel:

FRA:AGW2, ETR:AGW2, AGW2:GR

Index:

Webseite:

https://www.algernonhealt..

Profil:

Algernon Health Inc. is a clinical-stage biotechnology company specializing in the development of repurposed therapeutic drugs targeting serious medical conditions such as non-alcoholic steatohepatitis (NASH), chronic kidney disease, inflammatory bow..
>Volltext..

Marktkapitalisierung:

1.45 Mio. EUR

Unternehmenswert:

1.94 Mio. EUR

Umsatz:

EBITDA:

-1.15 Mio. EUR

Nettogewinn:

-1.2 Mio. EUR

Gewinn je Aktie:

-0.04 EUR

Schulden:

Liquide Mittel:

0.13 Mio. EUR

Operativer Cashflow:

-0.79 Mio. EUR

Bargeldquote:

0.09

Umsatzwachstum:

Gewinnwachstum:

-387.27%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ALGERNON HEALTH

Letzte Datenerhebung:

07.04.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 46.5 Mio. St.

Frei handelbar: 84.93%

Leerverk. Aktien: -

Rückkaufquote: -41.69%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: No rating

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 0.66

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -45.04%

Eigenkaprendite: -90.47%

>Peer Group

Gesundheit, Neurologische- & psychische Behandlung/ Schlaganfall, Nierenerkrankungen & -behandlung

>ALGERNON HEALTH Chart & Kurs - Stuttgart

>ALGERNON HEALTH News

01.04.26 - 01:12

Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation (GlobeNewswire EN)

VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, announces that it intends to change its corporate name from “Algernon Health Inc.” to “Grey Matters Health Inc.” (the “Name Change”). The Company has reserved the new name and new symbol “GREY” with the Canadian Securities Exchange (the “CSE”). The new symbols for the OTCQB and Frankfurt exchange will be provided shortly....

29.03.26 - 09:00	Algernon Health CEO outlines US brain imaging network plans - ICYMI (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

28.03.26 - 17:36	Algernon Health CEO outlines US brain imaging network plans - ICYMI (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

25.03.26 - 12:03

Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers (GlobeNewswire EN)

VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce NovaScan Neuroimaging ClinicsTM as the new brand name and visual identity for its planned U.S. network of brain PET scanning centers being launched at the HCA Florida University Medical Offices building in Davie, and featuring the U.S. FDA-cleared CareMiBrain™ system, a groundbreaking, standalone PET scanner without an integrated CT component....

24.03.26 - 10:00	Algernon Health to launch first U.S. brain PET clinic in Florida (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

23.03.26 - 20:12	Algernon Health to open brain-focused PET scanning clinic in Florida (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

20.01.26 - 14:01

Cytophage Announces Appointment of James Kinley as Chief Financial Officer (The Newswire)

WINNIPEG – TheNewswire - January 20, 2026 Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO; FSE: 70G) is pleased to announce the appointment of James Kinley, CPA CA, as Chief Financial Officer (CFO) of the Company. Mr. Kinley, based in Winnipeg, brings extensive experience in the biotech industry, having served as a CFO to several publicly listed healthcare companies over the past 15 years, including his current engagement as CFO to Algernon Health Inc (CSE: AGN). He will work with management and the Board of Directors to ensure continued compliance with the Company's financial reporting obligations and the requirements of applicable securities regulators and the TSX Venture Exchange. As a fractional CFO, the Company will also be able to benefit from cost savings in the appointment of Mr. Kinley. Mr. Kinley replaces Julius Kalcevich who has been the Company's CFO since July 2023. Mr. Kalcevich was brought on to take the Company public through a reverse takeover ( RTO) and...

21.10.25 - 23:54	XFRA: NEW INSTRUMENT AVAILABLE - 22.10.2025 - CA01559C1068 (XETRA)
	Das Instrument AGW2 CA01559C1068 ALGERNON HEALTH INC. A EQUITY hat seinen ersten Handelstag am 22.10.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument AGW2 CA01559C1068 ALGERNON HEALTH INC. A EQUITY has its first trading date on 22.10.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...

21.10.25 - 16:51

XFRA: ISIN Change (XETRA)

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA01559R4008 Algernon Pharmaceuticals Inc. 21.10.2025 CA01559C1068 Algernon Pharmaceuticals Inc. 22.10.2025 Tausch 1:1 CA62849F2008 Mydecine Innovations Group Inc. 21.10.2025 CA62849F4087 Mydecine Innovations Group Inc. 22.10.2025 Tausch 50:1 CA0682943059 Baroyeca Gold & Silver Inc. 21.10.2025 CA98956K1030 0749116 B C Ltd. 22.10.2025 Tausch 14:1 CA15643T6025 Centurion Minerals Ltd. 21.10.2025 CA15643T7015 Centurion Minerals Ltd. 22.10.2025 Tausch 4:1 CA60306F1018 Mineral Road Discovery Inc. 21.10.2025 CA60306F2008 Mineral Road Discovery Inc. 22.10.2025 Tausch 3:1 CA65345P1018 Nexus Uranium Corp. 21.10.2025 CA65345P2008 Nexus Uranium Corp. 22.10.2025 Tausch 10:1...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Unsere Gesellschaft hat viel mehr Vertrauen in Dinge, die sich nicht ändern. - Univ.-Prof. Mag. Dr. Markus Hengstschläger

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram